MK-0773
- Generic Name
- MK-0773
- Drug Type
- Small Molecule
- Chemical Formula
- C27H34FN5O2
- CAS Number
- 606101-58-0
- Unique Ingredient Identifier
- 5730VNW22X
- Background
MK-0773 is under investigation in clinical trial NCT00529659 (A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(mk-0773-005)).
Safety and Tolerability of MK0773 in Healthy Older Men (0773-004)
- First Posted Date
- 2009-11-20
- Last Posted Date
- 2016-07-12
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 68
- Registration Number
- NCT01017458
Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003)
- First Posted Date
- 2009-11-11
- Last Posted Date
- 2016-08-10
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 67
- Registration Number
- NCT01011725
A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005)
Phase 2
Completed
- Conditions
- Sarcopenia
- First Posted Date
- 2007-09-14
- Last Posted Date
- 2015-02-16
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 170
- Registration Number
- NCT00529659
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath